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CONCLUSIONS: An outcome guarantee is an acceptable
way for a nationally funded health service to partner a
pharmaceutical company for optimal diffusion of drugs
likely to beneﬁt a patient population. The model has
potential for replication in other therapeutic areas and
other healthcare systems.
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OBJECTIVE: Outcomes in healthcare technology reviews
now increasingly include cost as well as effectiveness. The
aim of this study is to report the ﬁndings and implications
of a survey regarding the usefulness of NHS Economic
Evaluation Database (NHS EED) structured abstracts
within this process. METHODS: Postal survey of lead
authors of Technology Assessment Reviews (TARs) com-
missioned by the UK’s National Institute for Clinical
Excellence. The questionnaire investigated the usefulness
of NHS EED regarding: search strategy, data extraction,
quality assessment, and requirement for new modeling
studies. Qualitative data were requested, including opin-
ions regarding NHS EED. RESULTS: NHS EED was used
in 90% of all identiﬁed reviews (n = 46). The question-
naire response rate was 57%. The percentage of scores 3
or above, 2 or below, or N/A were, respectively: search
strategy = 60%, 22%, 17%; data extraction = 26%,
26%, 48%; quality assessment = 30%, 22%, 48%;
requirement for new modeling studies = 22%, 26%,
52%. The results were expanded upon in the qualitative
data from the respondents. CONCLUSIONS: Where
several economic evaluations had been published NHS
EED was utilized and valued as an independent source,
and was highly useful to non-economists. However, those
undertaking TARs also used conﬁdential data from
company submissions and cost data for studies not cri-
tiqued on NHS EED. More standardization and use of
quality checklists in reviews of economic studies is clearly
needed. The ﬁndings will help in developing and improv-
ing NHS EED in its role of providing health outcomes
and economic evidence in TARs.
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OBJECTIVE: To estimate the most costly disease condi-
tions affecting medical, absenteeism, and short term dis-
ability (STD) expenditures affecting a subset of American
employers. METHODS: The Medstat Group’s 1999
Health and Productivity Management (HPM) Database
was used for this analysis. The HPM database links
medical, pharmacy, STD, and absence claims for over
340,000 employees. Medstat’s Episode Grouping soft-
ware product was used to classify and organize employ-
ees’ inpatient, outpatient, emergency department (ED)
and pharmaceutical claims temporally, so they could 
be connected to the treatment of any given condition.
Absence and STD claims associated with each clinical
episode were then added. The most costly physical and
mental health conditions were then ranked by their
overall medical, pharmacy, absence and STD expendi-
tures. RESULTS: Across all physical health conditions,
employers paid an average of $2505 per eligible employee
for medical care (71% of total), $316 per employee for
STD (9% of total), and $703 per employee in absence
(20% of total). Medical care expenditures included
money for: inpatient care–$687 (20% of total), out-
patient care–$1321 (38% of total), ED treatment–$57
(2% of total), and pharmaceuticals–$440 (12% of total).
When considering per-eligible payments for mental health
conditions, $94 (53% of total) was paid through health
beneﬁts, $23 (13% of total) was paid through STD pro-
grams, and $61 (34% of total) was as a result of employee
absence from work. Medical expenditures for mental
health care included money for inpatient care–$21 (12%
of total), outpatient care–$45 (25% of total), ED treat-
ment–$0.3 (0.2% of total), and pharmaceuticals–$28
(15% of total). CONCLUSIONS: Although health care
expenditures account for the majority of costs faced by
American businesses, productivity-related costs can be
high as well. Inpatient, outpatient, ED, and drug cost,
along with STD and absence costs, varied greatly by
disease.
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OBJECTIVE: Falls are a major problem for the 
community-dwelling elderly. About 30% of this group
experience a fall each year and between 4 and 10% 
of community-dwelling elders experience a fall-related
injury. Further, falling occurrence is a signiﬁcant predic-
tor of institutionalization and death. The objective of this
study was to provide an annual estimate of the direct
medical costs associated with fall-related injuries among
the community dwelling elderly. The study was done from
the payer’s perspective. METHODS: Data from the 1997
Medical Expenditure Panel Survey (MEPS) were analyzed
to identify elderly respondents who reported a fall-related
